December 16th, 2013 | Ben Hirschler | WHTC (Reuters)
LONDON (Reuters) - GlaxoSmithKline will stop paying doctors for promoting its drugs and scrap prescription targets for its marketing staff - a first for an industry battling scandals over its sales practices, and a challenge for its peers to follow suit. Britain’s biggest drugmaker also said on Tuesday it would stop payments to healthcare professionals for attending medical conferences as it tries to persuade critics it is addressing conflicts of interest that could put commercial interests ahead of the best outcome for patients.
December 16th, 2013 | Troy Graham | Philadelphia Inquirer
After getting swamped with e-mails and Facebook messages raising concerns about her plan to allow advertising at Philadelphia schools, City Councilwoman Blondell Reynolds Brown has hit the “pause” button.”Continue Reading...
December 16th, 2013 | Mike Dunn | CBS Local (Philadelphia)
City Council closed its 2013 legislative session with one key matter unresolved: whether to allow advertising on public school properties — to benefit the cash-starved district. The proposal to allow ads on schoolproperties had sailed out of committee earlier this month, and it was up for final passage this past week, on Council’s final meeting of 2013. But the sponsor, Councilwoman Blondell Reynolds Brown, decided to delay that final vote because of feedback she’d received since the committee hearing.
December 15th, 2013 | Mike Shields | Ad Week
According to comScore, the audience for online video has grown 4 percent over the past year. The number of video ads? Up 205 percent. Sure, people are watching a lot of online video. But the ad-serving firm Vindico sees something more nefarious in those numbers. “The number of ad impressions have exploded, but it’s totally manufactured viewing,” said Vindico president Matt Timothy. In fact, Vindico, which says it tracks 40 percent of all video ads served on the Web, found that 57 percent of 2.7 billion ads it tracked over a recent two-month period were not viewable.Continue Reading...
December 14th, 2013 | Alan Schwartz | The New York Times
After more than 50 years leading the fight to legitimize attention deficit hyperactivity disorder, Keith Conners could be celebrating. Severely hyperactive and impulsive children, once shunned as bad seeds, are now recognized as having a real neurological problem. Doctors and parents have largely accepted drugs like Adderall and Concerta to temper the traits of classic A.D.H.D., helping youngsters succeed in school and beyond.Continue Reading...